{
    "root": "c1b9b7ce-d5e5-4911-ad7a-667bc80b0ceb",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Metoprolol Tartrate",
    "value": "20250304",
    "ingredients": [
        {
            "name": "METOPROLOL TARTRATE",
            "code": "W5S57Y3A5L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6906"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYPROMELLOSE 2910 (3 MPA.S)",
            "code": "0VUT3PMY82",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "HYPROMELLOSE 2910 (50 MPA.S)",
            "code": "1IVH67816N",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "POLYDEXTROSE",
            "code": "VH2XOU12IE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_181906"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POLYETHYLENE GLYCOL 8000",
            "code": "Q662QK8M3B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9661"
        },
        {
            "name": "FD&C BLUE NO. 2 ALUMINUM LAKE",
            "code": "4AQJ3LG584"
        },
        {
            "name": "D&C RED NO. 27 ALUMINUM LAKE",
            "code": "ZK64F7XSTX"
        },
        {
            "name": "FD&C RED NO. 40 ALUMINUM LAKE",
            "code": "6T47AS764T"
        }
    ],
    "indications": {
        "text": "metoprolol tartrate tablets beta-adrenergic blocker indicated treatment : \u2022 hypertension , lower blood pressure . lowering blood pressure reduces risk fatal non-fatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) \u2022 angina pectoris . ( 1.2 ) \u2022 myocardial infarction , reduce risk cardiovascular mortality used conjunction intravenous metoprolol therapy patients definite suspected acute myocardial infarction hemodynamically stable patients . ( 1.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "myocardial infarction (DOID:5844)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5844"
            },
            {
                "text": "acute myocardial infarction (DOID:9408)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9408"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute myocardial infarction",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_95409"
            }
        ]
    },
    "contraindications": {
        "text": "\u2022 administer daily food meal . titrate weekly longer intervals needed tolerated . ( 2 ) \u2022 hypertension : recommended starting 100 mg daily , single divided doses . ( 2.1 ) \u2022 angina pectoris : recommended starting 100 mg daily , given two divided doses . ( 2.2 ) \u2022 myocardial infarction : starting depends upon tolerance intravenous metoprolol , full prescribing information . ( 2.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            },
            {
                "text": "myocardial infarction (DOID:5844)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_5844"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "metoprolol tartrate tablets , usp available containing 25 mg 50 mg metoprolol tartrate , usp . 25 mg tablets white , film-coated , round , scored tablets debossed mover 18on one side tablet scored side . available follows : overbagged 10 tablets per bag , ndc 55154-5356-0 50 mg tablets pink , film-coated , round , scored tablets debossed mover 32on one side tablet scored side . available follows : overbagged 10 tablets per bag , ndc 55154-5512-0 storage : store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) . [ usp controlled room temperature . ] protect light moisture .",
    "adverseReactions": "metoprolol tartrate tablets contraindicated severe bradycardia , second- third-degree heart block , cardiogenic shock , systolic blood pressure < 100 , decompensated heart failure , sick sinus syndrome ( unless permanent pacemaker place ) , patients hypersensitive component product .",
    "indications_original": "Metoprolol tartrate tablets are a beta-adrenergic blocker indicated for the treatment of: \u2022 Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) \u2022 Angina Pectoris. ( 1.2 ) \u2022 Myocardial Infarction, to reduce the risk of cardiovascular mortality when used in conjunction with intravenous metoprolol therapy in patients with definite or suspected acute myocardial infarction in hemodynamically stable patients. ( 1.3 )",
    "contraindications_original": "\u2022 Administer once daily with food or after a meal. Titrate at weekly or longer intervals as needed and tolerated. ( 2 ) \u2022 Hypertension: Recommended starting dosage is 100 mg daily, in single or divided doses. ( 2.1 ) \u2022 Angina Pectoris: Recommended starting dosage is 100 mg daily, given as two divided doses. ( 2.2 ) \u2022 Myocardial Infarction: The starting dosage depends upon tolerance of intravenous metoprolol, see full prescribing information. ( 2.3 )",
    "warningsAndPrecautions_original": "Metoprolol Tartrate Tablets, USP are available containing 25 mg or 50 mg of metoprolol tartrate, USP.\n                  The 25 mg tablets are white, film-coated, round, scored tablets debossed with     Mover     18on one side of the tablet and scored on the other side. They are available as follows:   \n                  Overbagged with 10 tablets per bag,\u00a0NDC 55154-5356-0\n                  The 50 mg tablets are pink, film-coated, round, scored tablets debossed with     Mover     32on one side of the tablet and scored on the other side. They are available as follows:   \n                  Overbagged with 10 tablets per bag,\u00a0NDC 55154-5512-0\n                  \n                     Storage:\n                     \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F). [See USP Controlled Room Temperature.]\n                     \n                     Protect from light and moisture.",
    "adverseReactions_original": "Metoprolol tartrate tablets are contraindicated in severe bradycardia, second- or third-degree heart block, cardiogenic shock, systolic blood pressure <100, decompensated heart failure, sick sinus syndrome (unless a permanent pacemaker is in place), and in patients who are hypersensitive to any component of this product.",
    "drug": [
        {
            "name": "Metoprolol Tartrate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6906"
        }
    ]
}